Woodline Partners’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Woodline Partners's CABA Position: Q3 2026 in Review
Woodline Partners increased its Cabaletta Bio (CABA) stake by 24% in Q3 2026, buying an estimated $2.82M and bringing the position to 5,200,642 shares worth $10M. The position accounts for 0.03% of the portfolio, ranked #557.
Woodline Partners first reported a position in CABA in Q3 2023 and has held it in 10 quarters since. The position peaked at $13.1M in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Woodline Partners held 5,200,642 shares of Cabaletta Bio worth $10M as of Q3 2026.
- Woodline Partners bought 1,000,500 Cabaletta Bio shares in Q3 2026, an estimated $2.82M.
- Cabaletta Bio made up 0.03% of Woodline Partners's portfolio in Q3 2026, its #557 holding.
- Woodline Partners first reported a position in Cabaletta Bio in Q3 2023 and has held it in 10 quarters since.
- Woodline Partners's Cabaletta Bio position peaked at $13.1M in Q2 2026.
- 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.